Your search history is turned on.
Date: April 6, 2021 Jurisdictions: British Columbia, Quebec
form6k-040621 FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of April 2021 Commission File Number: 001-38757 TAKEDA PHARMACEUTICAL COMPANY LIMITED (Translation of registrants name into English) 1-1, Nihon...
TAKEDA Wave 1 Market Event (Part 2) IR Event WAVE 1 PIPELINE MARKET OPPORTUNITY CALL (PART 2) April 6th, 2021 Takeda Pharmaceutical Company Limited IMPORTANT NOTICE For the purposes of this notice, presentation means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda...
Date: April 5, 2021 Jurisdictions: British Columbia, Quebec
form6k-040221 FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of April 2021 Commission File Number: 001-38757 TAKEDA PHARMACEUTICAL COMPANY LIMITED (Translation of registrants name into English) 1-1, Nihon...
Date: April 1, 2021 Jurisdictions: British Columbia, Quebec
form6k-040121 FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of April 2021 Commission File Number: 001-38757 TAKEDA PHARMACEUTICAL COMPANY LIMITED (Translation of registrants name into English) 1-1, Nihon...
Date: March 31, 2021 Jurisdictions: British Columbia, Quebec
form6k-2-033121 FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2021 Commission File Number: 001-38757 TAKEDA PHARMACEUTICAL COMPANY LIMITED (Translation of registrants name into English) 1-1, Nih...
form6k-1-033121 FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2021 Commission File Number: 001-38757 TAKEDA PHARMACEUTICAL COMPANY LIMITED (Translation of registrants name into English) 1-1, Nih...
Date: March 11, 2021 Jurisdictions: British Columbia, Quebec
PowerPoint Presentation DRIVING SUSTAINABLE GROWTH THROUGH INVESTMENTS IN INNOVATION AND PATIENT ACCESS GROWTH AND EMERGING MARKETS (GEM) INVESTOR DAY March 11, 2021 For the purposes of this notice, presentation means this document, any oral presentation, any question and answer session and any written or oral material discussed or distrib...
form6k-031121 FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2021 Commission File Number: 001-38757 TAKEDA PHARMACEUTICAL COMPANY LIMITED (Translation of registrants name into English) 1-1, Nihon...
Date: March 5, 2021 Jurisdictions: British Columbia, Quebec
form6k-030521 FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2021 Commission File Number: 001-38757 TAKEDA PHARMACEUTICAL COMPANY LIMITED (Translation of registrants name into English) 1-1, Nihon...
Date: February 26, 2021 Jurisdictions: British Columbia, Quebec
form6k-022621 FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of February 2021 Commission File Number: 001-38757 TAKEDA PHARMACEUTICAL COMPANY LIMITED (Translation of registrants name into English) 1-1, Ni...